
High-performing insurers outpace legacy firms in revenue as Reserv and Counterpart secure $175 million in funding. Regulators increase scrutiny on claim delays and bias, while new products emerge to cover algorithmic risks.
Transcript is currently not available for this episode.
AI Host persona trained on this episode